COVID Vaccine Initiative


The COVID Vaccine Initiative (CVI) aims to ensure the development of safe, effective, and accessible vaccines for those most vulnerable to COVID-19: aging populations and those living in low- and middle-income countries. It leverages HVP’s global clinical research consortium, including newly established collaborations with the Harvard T.H. Chan School of Public Health focused on deciphering effective immunity in aging populations; FHI 360, a global nonprofit research and human development organization with extensive experience working in low and middle-income countries; and the University of Minnesota’s Center for Infectious Disease Research and Policy, a global leader in addressing public health preparedness and emerging infectious disease response.

COVID Newsroom

Global COVID Lab Meeting

Aug 12, 2021

Steffen Mueller, Ph.D.

Codagenix

Global COVID Lab Meeting

Jul 29, 2021

Stanley Plotkin, M.D.

University of Pennsylvania, Johns Hopkins University

Global COVID Lab Meeting

Jul 15, 2021

Carl Dieffenbach, Ph.D.

NIAID

Global COVID Lab Meeting

Jul 01, 2021

Pamela Bjorkman, Ph.D.

Caltech

Global COVID Lab Meeting

Jun 17, 2021

Alessandro Sette, Ph.D. & Daniela Weiskopf, Ph.D.

La Jolla Institute for Immunology

Global COVID Lab Meeting

Jun 03, 2021

Douglas Nixon, M.D., Ph.D.

Weill Cornell Medical College